As of 2026-01-08, the Relative Valuation of Creo Medical Group PLC (CREO.L) is 75.80 GBP. This relative valuation is based on P/E multiples. With the latest stock price at 10.75 GBP, the upside of Creo Medical Group PLC based on Relative Valuation is 605.1%.
The range of the Relative Valuation is 49.82 - 87.68 GBP.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 21.4x | 19.0x |
| Forward P/E multiples | 12.2x - 19.5x | 18.0x |
| Fair Price | 49.82 - 87.68 | 75.80 |
| Upside | 363.5% - 715.6% | 605.1% |
| Date | P/E |
| 2026-01-02 | 2.50 |
| 2025-12-31 | 2.42 |
| 2025-12-30 | 2.43 |
| 2025-12-29 | 2.49 |
| 2025-12-24 | 2.49 |
| 2025-12-23 | 2.49 |
| 2025-12-22 | 2.49 |
| 2025-12-19 | 2.50 |
| 2025-12-18 | 2.48 |
| 2025-12-17 | 2.49 |
| 2025-12-16 | 2.46 |
| 2025-12-15 | 2.46 |
| 2025-12-12 | 2.46 |
| 2025-12-11 | 2.48 |
| 2025-12-10 | 2.54 |
| 2025-12-09 | 2.54 |
| 2025-12-08 | 2.55 |
| 2025-12-05 | 2.55 |
| 2025-12-04 | 2.48 |
| 2025-12-03 | 2.47 |
| 2025-12-02 | 2.47 |
| 2025-12-01 | 2.47 |
| 2025-11-28 | 2.48 |
| 2025-11-27 | 2.46 |
| 2025-11-26 | 2.45 |
| 2025-11-25 | 2.43 |
| 2025-11-24 | 2.48 |
| 2025-11-21 | 2.55 |
| 2025-11-20 | 2.60 |
| 2025-11-19 | 2.57 |
| 2025-11-18 | 2.51 |
| 2025-11-17 | 2.51 |
| 2025-11-14 | 2.61 |
| 2025-11-13 | 2.63 |
| 2025-11-12 | 2.72 |
| 2025-11-11 | 2.76 |
| 2025-11-10 | 2.76 |
| 2025-11-07 | 2.77 |
| 2025-11-06 | 2.72 |
| 2025-11-05 | 2.63 |
| 2025-11-04 | 2.76 |
| 2025-11-03 | 2.76 |
| 2025-10-31 | 2.77 |
| 2025-10-30 | 2.75 |
| 2025-10-29 | 2.75 |
| 2025-10-28 | 2.76 |
| 2025-10-27 | 2.73 |
| 2025-10-24 | 2.70 |
| 2025-10-23 | 2.69 |
| 2025-10-22 | 2.69 |